vs
Side-by-side financial comparison of Agilent Technologies (A) and ARCBEST CORP (ARCB). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $998.8M, roughly 1.8× ARCBEST CORP). Agilent Technologies runs the higher net margin — 17.0% vs -0.1%, a 17.1% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs 3.3%). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -3.7%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
ArcBest Corporation is a leading U.S.-based logistics and transportation solutions provider. It offers end-to-end supply chain services including less-than-truckload freight shipping, full truckload services, warehousing, expedited delivery, and customized logistics consulting, serving enterprise, small business, and government clients across North America and select global markets.
A vs ARCB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $998.8M |
| Net Profit | $305.0M | $-1.0M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 0.3% |
| Net Margin | 17.0% | -0.1% |
| Revenue YoY | 7.0% | 3.3% |
| Net Profit YoY | -4.1% | -133.1% |
| EPS (diluted) | $1.07 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $998.8M | ||
| Q4 25 | $1.9B | $972.7M | ||
| Q3 25 | $1.7B | $1.0B | ||
| Q2 25 | $1.7B | $1.0B | ||
| Q1 25 | $1.7B | $967.1M | ||
| Q4 24 | $1.7B | $1.0B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B |
| Q1 26 | $305.0M | $-1.0M | ||
| Q4 25 | $434.0M | $-8.1M | ||
| Q3 25 | $336.0M | $39.3M | ||
| Q2 25 | $215.0M | $25.8M | ||
| Q1 25 | $318.0M | $3.1M | ||
| Q4 24 | $351.0M | $29.0M | ||
| Q3 24 | $282.0M | $100.3M | ||
| Q2 24 | $308.0M | $46.9M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | 0.3% | ||
| Q4 25 | 23.8% | -0.8% | ||
| Q3 25 | 20.7% | 5.2% | ||
| Q2 25 | 18.0% | 3.6% | ||
| Q1 25 | 22.4% | 0.7% | ||
| Q4 24 | 24.0% | 3.8% | ||
| Q3 24 | 21.1% | 12.7% | ||
| Q2 24 | 23.1% | 4.5% |
| Q1 26 | 17.0% | -0.1% | ||
| Q4 25 | 23.3% | -0.8% | ||
| Q3 25 | 19.3% | 3.7% | ||
| Q2 25 | 12.9% | 2.5% | ||
| Q1 25 | 18.9% | 0.3% | ||
| Q4 24 | 20.6% | 2.9% | ||
| Q3 24 | 17.9% | 9.4% | ||
| Q2 24 | 19.6% | 4.4% |
| Q1 26 | $1.07 | $-0.05 | ||
| Q4 25 | $1.53 | $-0.35 | ||
| Q3 25 | $1.18 | $1.72 | ||
| Q2 25 | $0.75 | $1.12 | ||
| Q1 25 | $1.11 | $0.13 | ||
| Q4 24 | $1.23 | $1.21 | ||
| Q3 24 | $0.97 | $4.23 | ||
| Q2 24 | $1.05 | $1.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $86.4M |
| Total DebtLower is stronger | $3.0B | $223.7M |
| Stockholders' EquityBook value | $6.9B | $1.3B |
| Total Assets | $12.8B | $2.5B |
| Debt / EquityLower = less leverage | 0.44× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $86.4M | ||
| Q4 25 | $1.8B | $124.2M | ||
| Q3 25 | $1.5B | $132.6M | ||
| Q2 25 | $1.5B | $139.7M | ||
| Q1 25 | $1.5B | $98.7M | ||
| Q4 24 | $1.3B | $157.2M | ||
| Q3 24 | $1.8B | $191.1M | ||
| Q2 24 | $1.7B | $260.5M |
| Q1 26 | $3.0B | $223.7M | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | $214.1M | ||
| Q2 25 | $3.3B | $241.4M | ||
| Q1 25 | $3.3B | $214.2M | ||
| Q4 24 | $3.3B | $189.1M | ||
| Q3 24 | $2.1B | $180.5M | ||
| Q2 24 | $2.1B | $203.6M |
| Q1 26 | $6.9B | $1.3B | ||
| Q4 25 | $6.7B | $1.3B | ||
| Q3 25 | $6.4B | $1.3B | ||
| Q2 25 | $6.1B | $1.3B | ||
| Q1 25 | $6.0B | $1.3B | ||
| Q4 24 | $5.9B | $1.3B | ||
| Q3 24 | $5.9B | $1.3B | ||
| Q2 24 | $6.2B | $1.2B |
| Q1 26 | $12.8B | $2.5B | ||
| Q4 25 | $12.7B | $2.5B | ||
| Q3 25 | $12.2B | $2.5B | ||
| Q2 25 | $12.2B | $2.5B | ||
| Q1 25 | $11.9B | $2.4B | ||
| Q4 24 | $11.8B | $2.4B | ||
| Q3 24 | $11.0B | $2.4B | ||
| Q2 24 | $10.9B | $2.4B |
| Q1 26 | 0.44× | 0.17× | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | 0.16× | ||
| Q2 25 | 0.55× | 0.19× | ||
| Q1 25 | 0.56× | 0.17× | ||
| Q4 24 | 0.57× | 0.14× | ||
| Q3 24 | 0.36× | 0.14× | ||
| Q2 24 | 0.34× | 0.17× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $44.7M | ||
| Q3 25 | $362.0M | $98.2M | ||
| Q2 25 | $221.0M | $108.4M | ||
| Q1 25 | $431.0M | $-22.3M | ||
| Q4 24 | $481.0M | $56.8M | ||
| Q3 24 | $452.0M | $88.8M | ||
| Q2 24 | $333.0M | $133.7M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $36.9M | ||
| Q3 25 | $259.0M | $33.2M | ||
| Q2 25 | $107.0M | $80.9M | ||
| Q1 25 | $334.0M | $-36.8M | ||
| Q4 24 | $388.0M | $3.5M | ||
| Q3 24 | $360.0M | $23.9M | ||
| Q2 24 | $230.0M | $83.9M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 3.8% | ||
| Q3 25 | 14.9% | 3.2% | ||
| Q2 25 | 6.4% | 7.9% | ||
| Q1 25 | 19.9% | -3.8% | ||
| Q4 24 | 22.8% | 0.4% | ||
| Q3 24 | 22.8% | 2.2% | ||
| Q2 24 | 14.6% | 7.8% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 0.8% | ||
| Q3 25 | 5.9% | 6.2% | ||
| Q2 25 | 6.8% | 2.7% | ||
| Q1 25 | 5.8% | 1.5% | ||
| Q4 24 | 5.5% | 5.3% | ||
| Q3 24 | 5.8% | 6.1% | ||
| Q2 24 | 6.5% | 4.6% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | 2.50× | ||
| Q2 25 | 1.03× | 4.20× | ||
| Q1 25 | 1.36× | -7.13× | ||
| Q4 24 | 1.37× | 1.96× | ||
| Q3 24 | 1.60× | 0.89× | ||
| Q2 24 | 1.08× | 2.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ARCB
Segment breakdown not available.
